These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29906059)

  • 1. A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene.
    Michelini S; Cardone M; Haag M; Agga O; Bruson A; Maltese PE; Bonizzato A; Bertelli M
    Lymphology; 2016 Mar; 49(1):15-20. PubMed ID: 29906059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emberger syndrome: A rare association with hearing loss.
    Zawawi F; Sokolov M; Mawby T; Gordon KA; Papsin BC; Cushing SL
    Int J Pediatr Otorhinolaryngol; 2018 May; 108():82-84. PubMed ID: 29605372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation.
    Seo SK; Kim KY; Han SA; Yoon JS; Shin SY; Sohn SK; Moon JH
    Korean J Intern Med; 2016 Jan; 31(1):188-90. PubMed ID: 26767875
    [No Abstract]   [Full Text] [Related]  

  • 4. GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.
    Brambila-Tapia AJL; García-Ortiz JE; Brouillard P; Nguyen HL; Vikkula M; Ríos-González BE; Sandoval-Muñiz RJ; Sandoval-Talamantes AK; Bobadilla-Morales L; Corona-Rivera JR; Arnaud-Lopez L
    Hematology; 2017 Sep; 22(8):467-471. PubMed ID: 28271814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).
    Ostergaard P; Simpson MA; Connell FC; Steward CG; Brice G; Woollard WJ; Dafou D; Kilo T; Smithson S; Lunt P; Murday VA; Hodgson S; Keenan R; Pilz DT; Martinez-Corral I; Makinen T; Mortimer PS; Jeffery S; Trembath RC; Mansour S
    Nat Genet; 2011 Sep; 43(10):929-31. PubMed ID: 21892158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia.
    Vinh DC; Palma L; Storring J; Foulkes WD
    J Pediatr Hematol Oncol; 2018 May; 40(4):e225-e228. PubMed ID: 29620682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 is required for lymphatic vessel valve development and maintenance.
    Kazenwadel J; Betterman KL; Chong CE; Stokes PH; Lee YK; Secker GA; Agalarov Y; Demir CS; Lawrence DM; Sutton DL; Tabruyn SP; Miura N; Salminen M; Petrova TV; Matthews JM; Hahn CN; Scott HS; Harvey NL
    J Clin Invest; 2015 Aug; 125(8):2979-94. PubMed ID: 26214525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.
    Ishida H; Imai K; Honma K; Tamura S; Imamura T; Ito M; Nonoyama S
    Eur J Pediatr; 2012 Aug; 171(8):1273-6. PubMed ID: 22430350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GATA2 gene mutations: 3 cases].
    Perrard N; Pokeerbux MR; Quesnel B; Duployez N; Fenwarth L; Preudhomme C; Lefèvre G; Baillet C; Launay D; Terriou L
    Rev Med Interne; 2022 Nov; 43(11):677-682. PubMed ID: 36041908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.
    Rastogi N; Abraham RS; Chadha R; Thakkar D; Kohli S; Nivargi S; Prakash Yadav S
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):e383-e388. PubMed ID: 29189513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS.
    Saida S; Umeda K; Yasumi T; Matsumoto A; Kato I; Hiramatsu H; Ohara O; Heike T; Adachi S
    Pediatr Transplant; 2016 Mar; 20(2):333-6. PubMed ID: 26748574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases.
    Mansour S; Connell F; Steward C; Ostergaard P; Brice G; Smithson S; Lunt P; Jeffery S; Dokal I; Vulliamy T; Gibson B; Hodgson S; Cottrell S; Kiely L; Tinworth L; Kalidas K; Mufti G; Cornish J; Keenan R; Mortimer P; Murday V;
    Am J Med Genet A; 2010 Sep; 152A(9):2287-96. PubMed ID: 20803646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of GATA2 deficiency syndrome.
    Calvo KR; Hickstein DD
    Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin manifestations among GATA2-deficient patients.
    Polat A; Dinulescu M; Fraitag S; Nimubona S; Toutain F; Jouneau S; Poullot E; Droitcourt C; Dupuy A
    Br J Dermatol; 2018 Mar; 178(3):781-785. PubMed ID: 28440875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.